Somaxon Pharmaceuticals, Inc.·4

Feb 19, 7:30 PM ET

McGilley Meg 4

4 · Somaxon Pharmaceuticals, Inc. · Filed Feb 19, 2009

Insider Transaction Report

Form 4
Period: 2009-02-17
McGilley Meg
VP, CFO, Treasurer
Transactions
  • Award

    Common Stock

    2009-02-17+19,00974,721 total
  • Award

    Stock Option (right to purchase)

    2009-02-17+90,00090,000 total
    Exercise: $2.18Exp: 2019-02-16Common Stock (90,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    1,166
Footnotes (3)
  • [F1]These shares are represented by restricted stock units ("RSUs"). These RSUs will vest on the six month anniversary of the completion of a financing or a strategic collaboration (or last of a series of financing or collaboration transactions) yielding aggregate proceeds of $25 million or more to the Company during the calendar year 2009, subject to the reporting person's continued service to the Company through such vesting date.
  • [F2]25% of the number of shares of common stock subject to the option vest on the first anniversary of the date of grant, and 1/36 of the total remaining number of shares of common stock subject to the option vest on the first day of each month thereafter.
  • [F3]Not applicable to this transaction.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION